Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient-reported history of Dry Eye Disease in both eyes.~* Use of over the counter artificial tears within the past 30 days.~* A negative urine pregnancy test for females and willingness to use adequate birth control throughout the study.~* Able and willing to comply with all study procedures.~Exclusion Criteria:~* Presence of an ocular condition that could affect the study parameters such as active ocular infections, ocular inflammation, glaucoma, or diabetic retinopathy;.~* Unwilling to stop wearing contact lenses during the study.~* LASIK or other ocular surgical procedures within 12 months prior to or during the study.~* Use of prohibited medications~* Significant medical conditions that could affect the study parameters.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lifitegrast (Type: EXPERIMENTAL): Lifitegrast Ophthalmic Solution 5%, BID for 84 days
- Placebo (Type: PLACEBO_COMPARATOR): Placebo to match active treatment, BID for 84 days

Based on this trial design, predict the completion outcome and termination type (if applicable).